About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Mesalazine
- Procedure number
- PSUSA/00001990/202202
- Regulatory outcome
- Variation
Documents
Mesalazine : List of nationally authorised medicinal products - PSUSA/00001990/202202
English (EN) (602.72 KB - PDF)
Mesalazine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001990/202202
English (EN) (35.56 KB - PDF)
български (BG) (72.85 KB - PDF)
español (ES) (35.83 KB - PDF)
čeština (CS) (108.81 KB - PDF)
dansk (DA) (35.8 KB - PDF)
Deutsch (DE) (101.04 KB - PDF)
eesti keel (ET) (35.23 KB - PDF)
ελληνικά (EL) (108.64 KB - PDF)
français (FR) (34.85 KB - PDF)
hrvatski (HR) (68.12 KB - PDF)
íslenska (IS) (36.29 KB - PDF)
italiano (IT) (40.13 KB - PDF)
latviešu valoda (LV) (111.68 KB - PDF)
lietuvių kalba (LT) (78.67 KB - PDF)
magyar (HU) (108.88 KB - PDF)
Malti (MT) (72.09 KB - PDF)
Nederlands (NL) (38.05 KB - PDF)
norsk (NO) (40.41 KB - PDF)
polski (PL) (74.69 KB - PDF)
português (PT) (40.72 KB - PDF)
română (RO) (96.69 KB - PDF)
slovenčina (SK) (111.57 KB - PDF)
slovenščina (SL) (65.04 KB - PDF)
Suomi (FI) (40.27 KB - PDF)
svenska (SV) (39.43 KB - PDF)